Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Expanded newborn screening.

Marsha K Fearing1, Deborah Marsden

  • 1Children's Hospital Boston, Harvard Medical School Genetics Training Program, Boston, MA, USA.

Pediatric Annals
|August 29, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical manifestations, healthcare resource utilization, and costs among patients with long-chain fatty acid oxidation disorders: a retrospective claims database analysis.

Current medical research and opinion·2024
Same author

Disease characteristics, effectiveness, and safety of vestronidase alfa for the treatment of patients with mucopolysaccharidosis VII in a novel, longitudinal, multicenter disease monitoring program.

Orphanet journal of rare diseases·2024
Same author

Major clinical events and healthcare resource use among patients with long-chain fatty acid oxidation disorders in the United States: Results from LC-FAOD Odyssey program.

Molecular genetics and metabolism·2024
Same author

Mucopolysaccharidosis type VII (Sly syndrome) - What do we know?

Molecular genetics and metabolism·2024
Same author

Growth patterns in patients with mucopolysaccharidosis VII.

Molecular genetics and metabolism reports·2023
Same author

Estimating the Prevalence of Rare Diseases: Long-Chain Fatty Acid Oxidation Disorders as an Illustrative Example.

Advances in therapy·2022
Same journal

Management of Menstrual Disorders in Adolescents of All Abilities.

Pediatric annals·2026
Same journal

The Intersection of Weight Management and Eating Disorders.

Pediatric annals·2026
Same journal

Recognizing and Responding to Complexity in the Medical Care of Adolescents.

Pediatric annals·2026
Same journal

Language Development in Bilingual Children: A Pediatrician's Guide.

Pediatric annals·2026
Same journal

Navigating Identification and Management of Substance Use in Adolescents.

Pediatric annals·2026
Same journal

Risks and Benefits of Social Media on Adolescent Health.

Pediatric annals·2026
See all related articles

Expanded newborn screening detects metabolic disorders in infants before symptoms appear. This approach promises to reduce disease-related deaths and improve understanding of these conditions.

Area of Science:

  • Biochemistry
  • Genetics
  • Pediatrics

Background:

  • Expanded newborn screening enables early detection of numerous inborn errors of metabolism.
  • Advances in screening technology have significantly improved diagnostic capabilities for presymptomatic infants.

Purpose of the Study:

  • To highlight the impact of expanded newborn screening on identifying metabolic disorders.
  • To discuss the potential benefits of widespread screening implementation.

Main Methods:

  • Review of current expanded newborn screening protocols.
  • Analysis of diagnostic advancements in metabolic disease detection.

Main Results:

  • Successful identification of presymptomatic infants with various inborn errors of metabolism.

Related Experiment Videos

  • Demonstration of significant progress in early disease detection.

    • Conclusions:

    • Widespread implementation of expanded newborn screening is expected to decrease mortality and morbidity.
    • Screening expansion will enhance knowledge of disease frequency and phenotypic variability.